Schnell Biopharmaceuticals Inc. | Mutual Funds
Mutual Funds that own Schnell Biopharmaceuticals Inc.
iShares Core MSCI Emerging Markets ETF
1,325,194
1.23%
0
0.01%
09/05/2018
Vanguard Total International Stock Index Fund
1,069,616
0.99%
0
0%
07/31/2018
Government Pension Fund - Global (The)
432,798
0.4%
254,597
0%
12/31/2017
Vanguard Developed Markets Index Fund
430,068
0.4%
0
0%
07/31/2018
Vanguard FTSE All World (ex-US) Small Cap
189,618
0.18%
0
0.01%
07/31/2018
Mirae Asset TIGER Health Care ETF
167,197
0.16%
44,518
0.41%
04/30/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
161,634
0.15%
0
0.01%
09/05/2018
Schwab International Small Cap Equity ETF
134,508
0.13%
0
0.02%
09/06/2018
Vanguard Pacific Stock Index Fund
69,551
0.06%
0
0%
07/31/2018
iShares III Plc - MSCI Emerging Markets Small Cap
51,533
0.05%
0
0.04%
09/05/2018
| Address |
Room 301 Gangho Building
Seoul SL 06735
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.aprogen-pharm.com |
| Updated |
07/08/2019 |
| Aprogen Pharmaceuticals, Inc. engages in the manufacture and sale of pharmaceutical products. It operates throught the Pharmaceutical Manufacturing and Wholesale business divisions. The Pharmaceutical Manufacturing division provides antibiotics, antirhematics, and medicines for dermatopathy. |
